Bayes Pharma 2014 - final programme

Here’s the finalised programme for Bayes Pharma. (Of course I may be biased), but I think it is quite interesting and we have a wide variety of topics, so there should be plenty to get your teeth into! We still have some places available (and as always, students can register for free!).

Day 1 – 11 June 2014

9.00 - 9.30. Registration

Invited session 1. Bayesian Method in Clinical Trials: Priors from Historical Data

9.30 - 11.00. Beat Neuenschwander (Novartis)

11.00 - 11.30. Coffee break

11.30 - 12.30. David Dejardin (Bristol-Meyers-Squibb) & Emmanuel Lesaffre (Erasmus University Rotterdam)

12.30 - 13.30. Lunch break

Invited session 2. Advanced Bayesian modelling: Structural Equation Models

13.30 - 14.30. Peter Congdon (Queen Mary University London)

14.30 - 15.00. Coffee break

15.00 - 16.00. Phil Woodward (Pfizer). Advantages of a wholly Bayesian approach to assessing efficacy in early drug development: a case study

Contributed session 1

16.00 - 16.30. Haifang Ni (Utrecht University). Use of power priors to incorporate imperfect information in the analysis of veterinary clinical trials

16.30 - 17.00. Astrid Jullion (Novartis). Using mixture priors for robust inference: application in Bayesian dose escalation trials

Social Event

17.30 - 19.00. Trip to East London on a double-decker bus to visit Bayes tomb in Bunhill Fields

Day 2 – 12 June 2014
Invited session 3. Bayesian methods for exploratory and epidemiological analysis: Health economic evaluation 9.00 - 10.00. Chris Jackson (MRC Cambridge)

10.00 - 11.00. Richard Nixon (Novartis, Basel)

11.00 - 11.30. Coffee break

11.30 - 12.30. Gianluca Baio (UCL)

12.30 - 13.30. Lunch break

Contributed session 2

13.30 - 14.00. Nicky Welton (University of Bristol). Extrapolation of trial-based survival curves: constraints based on external information

14.00 - 14.30. Mohsen Mohammadzadeh (Tehran University). Bayesian Analysis of Spatio-Temporal Dynamic Panel Models with Fixed and Random Effects

14.30 - 15.00. Katrin Haussler (University College London). Bayesian health economic modelling of different human papillomavirus (HPV) vaccination strategies in a static and pseudo-dynamic setting: the BEST II study

15.00 - 15.30. Coffee break

Contributed session 3

15.30 - 16.00. Yingbo Wang (Imperial College London). Using Propensity Score to adjust for unmeasured confounders in small area studies

16.00 - 16.30. Eric Rozet (Arlenda). Transfer of analytical methods: the Bayesian way

16.30 - 17.00. Bayoue Li (Erasmus University Rotterdam). Joint modelling of a multilevel factor analytic model and a multilevel covariance regression model

Day 3 – 13 June 2014

Contributed session 4

9.30 - 10.00. Paul Meyvisch (Janssen). Optimizing sample size in relative bioavailability trials using a Bayesian decision theoretic framework

10.00 - 10.30. Foteini Strimenopoulou & Ros Walley (UCB). Clinical and pre-clinical applications of Bayesian methods at UCB

10.30 - 11.00. Moza Al-Balushi (Sultan Qaboos University). Determinants of Contraceptive Use in Oman: A Hierarchical Modeling Approach

11.00 - 11.30. Coffee break

Contributed session 5

11.30 - 12.00. Jean-François Michiels (Arlenda). A Bayesian framework for conducting effective bridging between references under uncertainty

12.00 - 12.30. Leandro Garcia-Barrado (Hasselt University). Incorporating post-development study information to reduce the sample size of diagnostic biomarker validation designs

12.30 - 13.00. Kazem Nasserinejad (Erasmus University Rotterdam). Bayesian growth mixture models to distinguish hemoglobin value trajectories in blood donors

13.00 - 13.10. Farewell

13.10 - 14.00. Lunch